World's Best Scientists 2026 revealed!
Seiichi Matsuo

Seiichi Matsuo

D-Index & Metrics

Medicine

D-Index
84
Citations
32700
World Ranking
14919
National Ranking
455

Seiichi Matsuo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Seiichi Matsuo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 474 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Seiichi Matsuo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Seiichi Matsuo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Seiichi Matsuo is affiliated with Nagoya University in Japan, where their research primarily focuses on medicine with a specialization in nephrology. Their scholarly output encompasses work in subfields such as pulmonary and respiratory medicine, pathology and forensic medicine, and immunology.

The scientist's research topics largely revolve around renal diseases and glomerulopathies, chronic kidney disease and diabetes, renal cell carcinoma treatment, autoimmune bullous skin diseases, and immunodeficiency and autoimmune disorders.

Their publication record includes papers in notable medical journals, with recent articles featuring in Clinical and Experimental Nephrology and International Urology and Nephrology. Selected recent papers include:

  • "Analysis of the impact of obesity on the prognosis of IgA nephropathy according to renal function and sex," published in 2024 in Clinical and Experimental Nephrology
  • "Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy," published in 2024 in International Urology and Nephrology

Collaboration forms a consistent part of their research activities. Frequent co-authors include Tatsuo Tsukamoto, Takashi Yasuda, Yoshinari Yasuda, Tetsuya Kawamura, and Eri Muso, each having co-authored multiple papers with Matsuo.

Best Publications

  • Revised equations for estimated GFR from serum creatinine in Japan.

    Seiichi Matsuo;Enyu Imai;Masaru Horio;Yoshinari Yasuda

  • Aspects of Immune Dysfunction in End-stage Renal Disease

    Sawako Kato;Michal Chmielewski;Michal Chmielewski;Hirokazu Honda;Roberto Pecoits-Filho

  • A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics

    Yoshifumi Takei;Kenji Kadomatsu;Yukio Yuzawa;Seiichi Matsuo

  • Prevalence of chronic kidney disease in the Japanese general population

    Enyu Imai;Masaru Horio;Tsuyoshi Watanabe;Kunitoshi Iseki

  • Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease

    Enyu Imai;Masaru Horio;Kosaku Nitta;Kunihiro Yamagata

  • Modification of the CKD Epidemiology Collaboration (CKD-EPI) Equation for Japanese: Accuracy and Use for Population Estimates

    Masaru Horio;Enyu Imai;Yoshinari Yasuda;Tsuyoshi Watanabe

  • Japan as the front‐runner of super‐aged societies: Perspectives from medicine and medical care in Japan

    Hidenori Arai;Yasuyoshi Ouchi;Kenji Toba;Tamao Endo

  • Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.

    Enyu Imai;Masaru Horio;Kunihiro Yamagata;Kunitoshi Iseki

  • Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient

    Enyu Imai;Masaru Horio;Kunitoshi Iseki;Kunihiro Yamagata

  • Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells

    Naotake Tsuboi;Yasunobu Yoshikai;Seiichi Matsuo;Takeshi Kikuchi

  • Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan.

    Enyu Imai;Masaru Horio;Kosaku Nitta;Kunihiro Yamagata

  • GFR Estimation Using Standardized Serum Cystatin C in Japan

    Masaru Horio;Enyu Imai;Yoshinari Yasuda;Tsuyoshi Watanabe

  • Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

    Kenjiro Kimura;Tatsuo Hosoya;Shunya Uchida;Masaaki Inaba

  • Non‐dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients

    Manchang Liu;Hiroshi Takahashi;Yoshiki Morita;Shoichi Maruyama

  • Neointima formation in a restenosis model is suppressed in midkine-deficient mice.

    Mitsuru Horiba;Kenji Kadomatsu;Eishin Nakamura;Hisako Muramatsu

  • Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury.

    Waichi Sato;Kenji Kadomatsu;Yukio Yuzawa;Hisako Muramatsu

  • Complement Activation Products in the Urine from Proteinuric Patients

    Yoshiki Morita;Hiroshi Ikeguchi;Jiro Nakamura;Nigishi Hotta

  • Localization of the complement regulatory proteins in the normal human kidney

    Shizunori Ichida;Yukio Yuzawa;Yukio Yuzawa;Yukio Yuzawa;Hidechika Okada;Hidechika Okada;Hidechika Okada;Kazuo Yoshioka;Kazuo Yoshioka;Kazuo Yoshioka

  • Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.

    Yoshifumi Takei;Kenji Kadomatsu;Seiichi Matsuo;Hiroshi Itoh

  • Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.

    Akiyoshi Hirayama;Eitaro Nakashima;Masahiro Sugimoto;Masahiro Sugimoto;Shin Ichi Akiyama

Frequent Co-Authors

Hirofumi Makino
Hirofumi Makino Okayama University
Kenji Kadomatsu
Kenji Kadomatsu Nagoya University
Toyoaki Murohara
Toyoaki Murohara Nagoya University
Enyu Imai
Enyu Imai Nagoya University
Yasuhiko Tomino
Yasuhiko Tomino Juntendo University
Hidechika Okada
Hidechika Okada Nagoya City University
Takashi Muramatsu
Takashi Muramatsu Nagoya University
Yasuo Ohashi
Yasuo Ohashi Chuo University
B. Paul Morgan
B. Paul Morgan Cardiff University
Yukihiro Noda
Yukihiro Noda Meijo University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing a traditional path in Medicine in the USA is popular, many prospective healthcare professionals consider online degree options for flexibility and affordability. For those interested in leadership roles in healthcare, exploring the cheapest mha online programs can be a cost-effective way to gain in-demand administrative skills while working in the field.

If you're already a registered nurse looking to advance, the most affordable online dnp programs offer pathways to the highest level of nursing practice. Similarly, those interested in pharmacy may benefit from choosing a pharmacy school online accredited program to work toward licensure from home.

For entry-level roles in health data and management, starting out with an him associate degree online can open doors to jobs in healthcare technology and information systems. These online programs provide alternative routes into fast-growing medical careers, offering affordability, convenience, and accredited education to suit diverse professional goals.

Best Scientists Citing Seiichi Matsuo

Trending Scientists

Recently Published Articles